These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10716580)

  • 1. Intraperitoneal insulin reduces plasma leptin concentration in diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
    Perit Dial Int; 2000; 20(1):27-32. PubMed ID: 10716580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
    Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
    Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
    Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
    Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperleptinemia in patients with end-stage renal disease undergoing continuous ambulatory peritoneal dialysis.
    Dagogo-Jack S; Ovalle F; Landt M; Gearing B; Coyne DW
    Perit Dial Int; 1998; 18(1):34-40. PubMed ID: 9527027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of continuous ambulatory peritoneal dialysis on change in serum leptin.
    Kim DJ; Oh DJ; Kim B; Lim YH; Kang WH; Lee BH; Lee SK; Huh W; Kim SE; Lee MK; Kang SA; Oh HY
    Perit Dial Int; 1999; 19 Suppl 2():S172-5. PubMed ID: 10406513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
    Perit Dial Int; 1996; 16 Suppl 1():S288-91. PubMed ID: 8728209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials.
    Almalki MH; Altuwaijri MA; Almehthel MS; Sirrs SM; Singh RS
    Clin Invest Med; 2012 Jun; 35(3):E132-43. PubMed ID: 22673316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.
    Nevalainen PI; Kallio T; Lahtela JT; Mustonen J; Pasternack AI
    Perit Dial Int; 2000; 20(6):637-42. PubMed ID: 11216552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment.
    Lahtela JT; Mustonen J; Pasternack A
    Clin Sci (Lond); 1995 Apr; 88(4):427-32. PubMed ID: 7789044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD.
    Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE
    Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
    Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
    Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement.
    Wong TY; Chan JC; Szeto CC; Leung CB; Li PK
    Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
    Tzamaloukas AH; Oreopoulos DG
    Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
    Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
    Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin in CAPD patients: serum concentrations and peritoneal loss.
    Kagan A; Haran N; Leschinsky L; Shuali N; Rapoport J
    Nephrol Dial Transplant; 1999 Feb; 14(2):400-5. PubMed ID: 10069196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.